Mission Wealth Management LP lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 17.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,282 shares of the medical research company’s stock after purchasing an additional 4,233 shares during the period. Mission Wealth Management LP’s holdings in Agilent Technologies were worth $3,757,000 at the end of the most recent reporting period.
Other institutional investors also recently added to or reduced their stakes in the company. Core Wealth Advisors LLC purchased a new position in Agilent Technologies in the fourth quarter valued at about $26,000. SHP Wealth Management bought a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $26,000. Navalign LLC purchased a new position in Agilent Technologies in the fourth quarter valued at approximately $27,000. Cedar Mountain Advisors LLC bought a new position in Agilent Technologies during the first quarter valued at $27,000. Finally, MV Capital Management Inc. purchased a new stake in Agilent Technologies in the fourth quarter worth $28,000.
Agilent Technologies Stock Down 0.8%
Shares of NYSE A opened at $148.28 on Thursday. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm’s 50 day simple moving average is $134.90 and its two-hundred day simple moving average is $125.30. The stock has a market capitalization of $41.88 billion, a P/E ratio of 29.78, a PEG ratio of 2.65 and a beta of 1.25.
Agilent Technologies Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s payout ratio is 20.48%.
Wall Street Analyst Weigh In
Several research firms have issued reports on A. Sanford C. Bernstein began coverage on Agilent Technologies in a research report on Friday, June 26th. They set an “outperform” rating and a $155.00 target price on the stock. Barclays boosted their price objective on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. Finally, Royal Bank Of Canada initiated coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $160.24.
Get Our Latest Report on Agilent Technologies
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Recommended Stories
- Five stocks we like better than Agilent Technologies
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
